Article
In situ carcinoma - can we predict which patient will come back with a recurrence?
Cancer cell - 1 Nov 2007
Simpson Peter T, Da Silva Leonard M, Lakhani Sunil R
Abstract excerpt
The frequency of in situ carcinomas has been rising since the introduction of mammographic screening. The management of patients with preinvasive disease remains difficult due to our lack of ability to accurately predict which patients will recur and progress to invasive carcinoma. Although some...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
